Vinayak Nayak

Mr. Vinayak Nayak

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Rout George KerryRout George Kerry
Rout George Kerry
FMFrancis Jesmar Perez Montalbo
Francis Jesmar Perez Montalbo
RDRajarshi Das
Rajarshi Das
SPSushmita Patra
Sushmita Patra
GMGyana Prakash Mahapatra
Gyana Prakash Mahapatra
JRJyoti Ranjan Rout
Jyoti Ranjan Rout

15 July 2023 in Environmental Research
Verified
Journal Article
Closed access
VNVinayak Nayak
Vinayak Nayak
SPSushmita Patra
Sushmita Patra
Kshitij RB SinghKshitij RB Singh
Kshitij RB Singh
BGBristy Ganguly
Bristy Ganguly
DKDas Nishant Kumar
Das Nishant Kumar
Rout George KerryRout George Kerry
Rout George Kerry

15 October 2023 in Phytomedicine
Verified
Journal Article
Closed access
VNVinayak Nayak
Vinayak Nayak
SPSushmita Patra
Sushmita Patra
SRShrushti Rout
Shrushti Rout
Atala Bihari jenaAtala Bihari jena
Atala Bihari jena
Rohit SharmaRohit Sharma
Rohit Sharma
Rout George KerryRout George Kerry
Rout George Kerry

10 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SDShyam Singh Dahiya
Shyam Singh Dahiya
SSSaravanan Subramaniam
Saravanan Subramaniam
JMJajati Keshari Mohapatra
Jajati Keshari Mohapatra
MRManoranjan Rout
Manoranjan Rout
JBJitendra Biswal
Jitendra Biswal
RSRabindra Prasad Singh
Rabindra Prasad Singh
In India, widespread foot-and-mouth disease (FMD) outbreaks occurred in 2021. The objective of this study was to identify genetic lineages and evaluate the antigenic relationships of FMD virus (FMDV) isolates gathered from outbreaks reported between 2019 and 2022. Our study shows that the lineages O/ME–SA/Ind2001e and the O/ME–SA/Cluster-2018 were both responsible for the FMD outbreaks on an epidemic scale during 2021. This observation is in contrast to earlier findings that suggested epidemic-scale FMD outbreaks in India are often connected to a single genetic lineage. Additionally, we report here the identification of the O/ME–SA/PanAsia-2/ANT10 sub-lineage in India for the first time, which was connected to two intermittent outbreaks in Jammu and Kashmir. The current study demonstrates that the O/ME–SA/ind2001e lineage has a strong presence outside of the Indian subcontinent. Furthermore, the O/ME–SA/Cluster-2018 was observed to have a wider geographic distribution than previously, and like the O/ME–SA/Ind2001d and O/ME–SA/Ind2001e lineages in the past, it may eventually spread outside of its geographic niche. For O/ME–SA/Ind2001e and O/ME–SA/Cluster-2018, the predicted substitution rate for the VP1 region was 6.737 × 10−3 and 8.257 × 10−3 nt substitutions per site per year, respectively. The time of the most recent common ancestor of the O/ME–SA/Ind2001e and O/ME–SA/Cluster-2018 strains suggests that the viruses possibly emerged during 2003–2011 and 2009–2017, respectively. Recent sightings of the O/ME–SA/PanAsia2/ANT10 virus in India and the O/ME–SA/Ind2001e virus in Pakistan point to possible cross-border transit of the viruses. The results of a two-dimensional viral neutralization test revealed that all of the field isolates were antigenically matched to the currently used Indian vaccine strain O INDR2/1975. These results suggest that the serotype O vaccine strain can protect against outbreaks brought on by all three circulating lineages.

9 April 2024 in Experimental Cell Research
Verified
Journal Article
Closed access
TSTaruna Saini
Taruna Saini
PGParth Gupta
Parth Gupta
RRRajnikant Dilip Raut
Rajnikant Dilip Raut
VNVinayak Nayak
Vinayak Nayak
PBPabbithi Bharathnaveen
Pabbithi Bharathnaveen
AMAshish Misra
Ashish Misra

26 February 2026 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
GSGopu Sandeep
Gopu Sandeep
SPSrijoni Pahari
Srijoni Pahari
VNVinayak Nayak
Vinayak Nayak
Rohit GundamarajuRohit Gundamaraju
Rohit Gundamaraju
PMParul Mishra
Parul Mishra
AMAshish Misra
Ashish Misra
Prostate cancer remains one of the most common malignancies in men, with its progression strongly influenced by androgen signaling. While genetic alterations are well-documented in prostate cancer, growing evidence highlights the contribution of environmental factors, particularly diet and the gut microbiome, in modulating disease risk and therapy response. The gut microbiota plays a crucial role in regulating host metabolism, immune responses, and hormone activity. Recent findings suggest that specific microbial communities influence androgen biosynthesis and metabolism through enzymes such as β-glucuronidase, altering systemic androgen availability and imp acting tumor progression. Additionally, microbial metabolites, including short-chain fatty acids, secondary bile acids, and bacterial genotoxins, can affect inflammatory pathways and cellular signaling relevant to prostate tumorigenesis. Experimental studies also indicate that modifying the gut microbiota through dietary interventions, probiotics, or fecal microbiota transplantation can influence tumor growth and improve responses to immunotherapy and hormone-based treatments. In this review we present the current knowledge on gut–prostate axis, examine the mechanistic links between microbial activity and prostate cancer biology, and discuss emerging microbiome-based strategies as potential therapies. A deeper understanding of this bidirectional crosstalk could pave the way for microbiome-informed approaches to prevention, diagnosis, and personalized treatment of prostate cancer